Form 4: Immunovant Chief Medical Officer Sells Shares to Cover Tax Obligations

William L. Macias, Chief Medical Officer of Immunovant, Inc., sold shares to cover tax withholding obligations related to the vesting of restricted stock units.

Summary

• William L. Macias, the Chief Medical Officer of Immunovant, Inc., sold 3,247 shares of common stock on May 22, 2024.
• The shares were sold at a weighted average price of $29.65, with individual transactions ranging from $29.31 to $30.02 per share.
• This sale was to cover tax withholding obligations associated with the vesting of 7,051 restricted stock units (RSUs) on May 17, 2024, which were part of a grant of 112,816 RSUs from August 17, 2022.
• The sale was mandated by Immunovant's policy requiring 'sell to cover' transactions for tax obligations and was not a discretionary transaction by Macias.
• Following the transaction, Macias still beneficially owns 374,403 shares of Immunovant common stock.

Sentiment

Score: 5

Explanation: The document describes a routine transaction (sell to cover taxes) by an officer, which is neither particularly positive nor negative for the company's outlook.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates